Solstice Oncology Raises $225 Million Series A To Advance Porustobart Cancer Therapy – Pulse 2.0 ↗
Google News
Solstice Oncology Raises $225 Million Series A To Advance Porustobart Cancer Therapy Pulse 2.0
FDA Approves Camizestrant: Key Nursing Roles in New Breast Cancer Paradigm – Oncology Nursing News ↗
Google News
FDA Approves Camizestrant: Key Nursing Roles in New Breast Cancer Paradigm Oncology Nursing News
FDA Approves Camizestrant for ESR1-Mutated Advanced Breast Cancer – Oncology Nursing News ↗
Google News
FDA Approves Camizestrant for ESR1-Mutated Advanced Breast Cancer Oncology Nursing News
US Approves Etcamah, CDK4/6 Inhibitor for 1st-Line HR+ Breast Cancer – Mirage News ↗
Google News
US Approves Etcamah, CDK4/6 Inhibitor for 1st-Line HR+ Breast Cancer Mirage News
Polymetastatic Disease Management: New Roles for SABR and LDRT – Oncology Nurse Advisor ↗
Google News
Polymetastatic Disease Management: New Roles for SABR and LDRT Oncology Nurse Advisor
Illness perceptions and symptom burden in chemotherapy-induced peripheral neuropathy: a moderated mediation analysis from a self-regulatory perspective ↗
Journal of Cancer Survivorship
Purpose Methods Results Conclusions Implications for cancer survivors
AbbVie’s blood cancer therapy lowers disease progression, death risk in trial – whbl.com ↗
Google News
AbbVie’s blood cancer therapy lowers disease progression, death risk in trial whbl.com
How transplant oncology is rewriting the story of liver cancer – The Hindu ↗
Google News
How transplant oncology is rewriting the story of liver cancer The Hindu
One step forward, two steps back: a qualitative study of clinical perspectives on implementing exercise in neuro-oncology care ↗
Journal of Cancer Survivorship
Background Methods Results Conclusion Implications for Cancer Survivors Clinical Trials Registration
